| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |